Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.43 |
| ▸ | POLB | P06746 | 6/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3513899 | 1.00 | HCAR2 (0.69) | HCAR2MAPTALDH1A1ALOX5MAOA | |
| SCHEMBL7893859 | 0.82 | HCAR2 (1.00) | HCAR2MAPTALDH1A1ALOX5MAOA | |
| SCHEMBL660178 | 0.82 | HCAR2 (1.00) | HCAR2MAPTALDH1A1ALOX5MAOA | |
| SCHEMBL564789 | 0.82 | HCAR2 (1.00) | HCAR2MAPTALDH1A1ALOX5MAOA | |
| SCHEMBL1380933 | 0.80 | HCAR2 (0.69) | HCAR2MAPTALDH1A1ALOX5MAOA | |
| Hydrochloric Acid SCHEMBL9261463 | 0.80 | HCAR2 (0.96) | HCAR2MAPTALDH1A1ALOX5MAOA | |
| SCHEMBL28981304 | 0.80 | HCAR2 (0.69) | HCAR2MAPTALDH1A1ALOX5MAOA | |
| SCHEMBL2815054 | 0.80 | HCAR2 (0.69) | HCAR2MAPTALDH1A1ALOX5MAOA | |
| SCHEMBL13692335 | 0.80 | HCAR2 (0.69) | HCAR2MAPTALDH1A1ALOX5MAOA | |
| SCHEMBL17200022 | 0.78 | HCAR2 (0.56) | HCAR2MAPTALDH1A1MAOBPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109970747-B | Method for preparing 10 α -hydroxynalfuraphten | 潍坊科技学院 | 2020-07-24 | — | — | CN | claimed |
| EP-4577204-A1 | MULTIPLE TARGETING OPIOID RECEPTOR LIGANDS AS NOVEL ANALGESICS WITH MINIMUM ABUSE LIABILITY | Virginia Commonwealth University (US) | 2025-07-02 | — | — | EP | disclosed |
| CN-119350353-A | Nalfarfene hydrochloride intermediate and preparation method thereof | 北京阳光诺和药物研究股份有限公司 | 2025-01-24 | — | — | CN | disclosed |
| WO-2024044179-A1 | MULTIPLE TARGETING OPIOID RECEPTOR LIGANDS AS NOVEL ANALGESICS WITH MINIMUM ABUSE LIABILITY | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2024-02-29 | — | — | WO | disclosed |
| CN-109970747-B | Method for preparing 10 α -hydroxynalfuraphten | 潍坊科技学院 | 2020-07-24 | — | — | CN | disclosed |
| US-8481129-B2 | Liquid crystal compounds, and liquid crystal displays and photochromic materials comprising the liquid crystal compounds | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-07-09 | — | — | US | disclosed |
| US-8481129-B2 | Liquid crystal compounds, and liquid crystal displays and photochromic materials comprising the liquid crystal compounds | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-07-09 | — | — | US | disclosed |
| US-20130135574-A1 | LIQUID CRYSTAL COMPOUNDS, AND LIQUID CRYSTAL DISPLAYS AND PHOTOCHROMIC MATERIALS COMPRISING THE LIQUID CRYSTAL COMPOUNDS | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-05-30 | — | — | US | disclosed |
| US-20130135574-A1 | LIQUID CRYSTAL COMPOUNDS, AND LIQUID CRYSTAL DISPLAYS AND PHOTOCHROMIC MATERIALS COMPRISING THE LIQUID CRYSTAL COMPOUNDS | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-05-30 | — | — | US | disclosed |
| US-20040181062-A1 | Benzimidazole cyclooxygenase-2 inhibitor | PFIZER INC | 2004-09-16 | — | — | US | disclosed |
| CN-1111900-A | Antitussive | TORAY INDUSTRIES (JP) | 1995-11-15 | — | — | CN | disclosed |
| EP-0663401-A1 | MORPHINAN DERIVATIVE AND MEDICINAL USE | TORAY INDUSTRIES, INC. (JP) | 1995-07-19 | — | — | EP | disclosed |
| EP-0661283-A1 | BRAIN CELL PROTECTIVE | TORAY INDUSTRIES, INC. (JP) | 1995-07-05 | — | — | EP | disclosed |
| EP-0657163-A1 | ANTITUSSIVE | TORAY INDUSTRIES, INC. (JP) | 1995-06-14 | — | — | EP | disclosed |
| US-5411970-A | Method of inhibiting lentivirus | G. D. SEARLE & CO. (US) | 1995-05-02 | — | — | US | disclosed |
| US-5310745-A | Acylated derivatives of 1,5-dideoxy-1,5-imino-D-glucitol, AIDS | G. D. SEARLE & CO. (US) | 1994-05-10 | — | — | US | disclosed |
| EP-0577847-A1 | MORPHINAN DERIVATIVE AND MEDICINAL USE | TORAY INDUSTRIES, INC. (JP) | 1994-01-12 | — | — | EP | disclosed |
| US-5221746-A | Inhibitors of visna virus; treatment of AIDS and ARC | G. D. SEARLE & CO. (US) | 1993-06-22 | — | — | US | disclosed |
| US-5144037-A | Viricides | G. D. SEARLE & CO. (US) | 1992-09-01 | — | — | US | disclosed |
| EP-0494850-A2 | Novel antiviral compounds | G.D. Searle & Co. (US) | 1992-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130135574-A1 | LIQUID CRYSTAL COMPOUNDS, AND LIQUID CRYSTAL DISPLAYS AND PHOTOCHROMIC MATERIALS COMPRISING THE LIQUID CRYSTAL COMPOUNDS | H1-0, H1-10, FOXK1 | HCAR2 4071/4885MAPT 1517/4885ALDH1A1 2343/4885 |
| US-20040181062-A1 | Benzimidazole cyclooxygenase-2 inhibitor | PTGS1, CBR1, CBR3 | HCAR2 111/4885MAPT 4736/4885ALDH1A1 203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.